Aptevo Therapeutics Inc. Gains 48.01%

Tue, Oct 22, 2024 at 07:52 PM

Aptevo Therapeutics Inc. (APVO:NASDAQ) soared at $0.35, representing a gain of 48%. On Tue, Oct 22, 2024, APVO:NASDAQ touched a New 2-Week High of $0.35. From Tue, Oct 08, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days

The stock spiked on Tue, Oct 22, 2024 at $0.52 with a volume of 134M+.

About Aptevo Therapeutics Inc. (APVO:NASDAQ)

Aptevo Therapeutics Inc is a biosciences company. The Company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics.

Top 10 Gainers:

Ensysce Biosciences Inc. (ENSC:NASDAQ), 161.65%
Genprex, Inc. (GNPX:NASDAQ), 137.75%
ENDRA Life Sciences Inc. (NDRA:NASDAQ), 90.22%
Allakos Inc. (ALLK:NASDAQ), 57.04%
Digital Brands Group Inc. (DBGI:NASDAQ), 49.63%
Aptevo Therapeutics Inc. (APVO:NASDAQ), 48.01%
Armlogi Holding Corp. (BTOC:NASDAQ), 47.7%
F45 Training Holdings Inc. (FXLV:NYSE), 40.74%
Phunware, Inc. (PHUN:NASDAQ), 38.41%
noco-noco Inc. (NCNC:NASDAQ), 37.39%